Sudden cardiac death and implantable cardioverter-defibrillators.

Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: too little and too late?

Frequency and Determinants of Implantable Cardioverter Defibrillator Deployment Among Primary Prevention Candidates With Subsequent Sudden Cardiac Arrest in the Community Kumar Narayanan, MD; Kyndaron Reinier, PhD; Audrey Uy-Evanado, MD; Carmen Teodorescu, MD, PhD; Harpriya Chugh, BS; Eloi Marijon, MD; Karen Gunson, MD; Jonathan Jui, MD, MPH; Sumeet S. Chugh, MD CME . . . . . . . . . . . . . . ...

Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Im

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is an important cardiovascular disease with sudden cardiac death as the most devastating presentation. Implantable cardioverter defibrillators (ICD) are the optimal therapy for prevention of sudden death from ventricular tachycardia or fibrillation of any cause. While there is no controversy with implanting ICDs in patients who have already survived a cardiac a...

Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.

Much of the public was introduced to the implantable cardioverter-defibrillator (ICD) when Vice President Cheney, a survivor of four heart attacks, received the device in 2001. Although ICDs were initially limited to patients with previous cardiac arrests or arrhythmias, more recent studies have demonstrated that ICDs can prevent sudden cardiac death in patients who have not had a cardiac arres...

Defibrillator implantation for the primary prevention of sudden death in patients awaiting cardiac transplantation: one center's experience.

Patients who are on a waiting list for cardiac transplantation often have a clinical profile that satisfies current recommendations for the implantation of an implantable cardioverter-defibrillator for the primary prevention of sudden death. The prospect that transplantation may take place within the short-to-medium term puts the effectiveness of this therapy in doubt. We investigated the incid...

Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers

Implantable cardioverter-defibrillators (ICDs) improve the survival in patients at risk of sudden cardiac death. However, these patients have an ongoing risk of sudden incapacitation that may cause harm to individuals and others when driving. Considerable disagreement exists about whether and when these patients should be allowed to resume driving after ICD therapies. This information is critic...